J

Jakkajangreddy

Active Director Director DIN 07817130
DIN 07817130 First appointment May 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2017
Shareholding value •••• Premium profile

About Jakkajangreddy

Data last updated:

Jakkajangreddy is a Director at Nuvista Pharmaceuticals Private Limited (since 2017). The company operates in Pharma. Nuvista Pharmaceuticals Private Limited reported revenue of ₹10.25 Cr (FY 2023).

DIN 07817130
Primary Designation Director
Industry Pharma
First Appointment 18 May 2017
Oldest Company Age 9 yrs
Largest company Nuvista Pharmaceuticals Private Limited · ₹10.25 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 May 20172017₹10.25 Cr (FY 2023)Active

Directorship timeline

Open interactive timeline →
Nuvista Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jakkajangreddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jakkajangreddy

Jakkajangreddy currently holds 1 directorship: Nuvista Pharmaceuticals Private Limited (Director, since 18 May 2017, revenue ₹10.25 Cr (FY 2023)).

Jakkajangreddy was first appointed on 18 May 2017 as Director at Nuvista Pharmaceuticals Private Limited.

The current boards of Jakkajangreddy's companies include Kallam Srikantha Reddy (Nuvista Pharmaceuticals Private Limited), Masaram Venkataiah Goud (Nuvista Pharmaceuticals Private Limited), Sudhakara Reddy Kalakota (Nuvista Pharmaceuticals Private Limited), Surya Rao Yechuri (Nuvista Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available